Tanios Bekaii-Saab, MD joined the faculty at The Ohio State University – Arthur G. James Cancer Hospital and Solove Research Institute in 2002 where he is a tenured Associate Professor of Medicine and Pharmacology and section chief for the gastrointestinal cancer program. He is also the chairman of the disease specific research group for the comprehensive cancer center. Dr. Bekaii-Saab earned his medical degree from the American University of Beirut in Lebanon, followed by residency in internal medicine at Indiana University Medical Center in Indianapolis, Indiana. He completed fellowships in clinical pharmacology and experimental therapeutics and hematology/oncology at Tufts University/New England Medical Center in Boston, Massachusetts.
Dr Bekaii-Saab’s research interests include experimental therapeutics/translational research focused on gastrointestinal malignancies, molecular targeted and immune therapies. He is the principal investigator on numerous clinical trials, including studies supported through research grants from the National Cancer Institute (NCI) and the National Comprehensive Cancer Network (NCCN). He is also the recipient of numerous research grants from various industry partners. Dr. Bekaii-Saab is also the recipient of the prestigious NCI clinical investigator team leadership award and the ASCO leadership program development award. Additionally, he has been listed in U.S. News and World Report’s Top Doctors and is one of the Best Doctors in America.
Dr Bekaii-Saab is actively involved in a number of professional societies including the American Society of Clinical Oncology, American Association for Cancer Research, American Society for Clinical Pharmacology and Therapeutics, and the Alliance cooperative group. He also serves as a member on the Colorectal Cancer Panel for NCCN. In addition, he has served as a reviewer for over 50 journals, as journal editorial board member of JNCCN, World Journal of Hepatology, US Oncological Review, and HemOnc Today, and has authored over 100 publications and 130 abstracts in a number of journals including Journal of Clinical Oncology, Annals of Oncology and Clinical Cancer Research.